Gates Foundation Strategic Investment Fund Logo
Share this page:

Just Biotherapeutics


Just Biotherapeutics is developing an integrated technology platform to accelerate the development and manufacturing of high-quality biologics at a significantly lower cost, to broaden global biologic access. The foundation’s investment supported the construction of a manufacturing facility in exchange for access to low-cost production of global health product candidates. The foundation is also supporting Just’s technology development and partnering with the company on multiple products.

Investment Date: June 2016